Study on Qianliejindan in treatment of benign prostatic hyperplasia with chronic nonbacteroal prostatitis /chronic pelvic pain syndrome
SUN Xi-guo
XU Bin
WANG Kui-jun
ZHOU Fang-kun
LI Cun-jie
ZHOU Wen-bo
Abstract：Objective To observe the influence of Qianliejindan in the treatment of the benign prostatic hyperplasia(BPH) with chronic nonbacterial prostatitis/chronic pelvic pain syndrome(CNBP/CPPS).Methods All 100 patients with BPH and CNBP/CPPS were randomly allocated to treatment group and control group in a doubleblind clinic trial.Treatment group was received Qianliejindan while control group was received placebo.After treatment for 3 months,the evaluating indexes included IPSS,NIH-CPSI,peak urinary flow rate,postvoid residual (PVR) volume and WBC count in EPS were evaluated.Results Three months after treatment,the IPSS scores of treatment group and control group decreased from ( 12.6 ± 2.5) and ( 12.4 ± 2.4) to ( 10.3 ± 2.2 ) and ( 12.1 ±2.5 ),and there was significant difference in treatment group( P ＜ 0.05) ; the CPSI scores decreased from(23.0 ±5.9 ) and ( 23.9 ± 6.0) to ( 16.6 ± 4.5 ) and (22.7 ± 5.9),and there was significant difference in treatment group ( P ＜ 0.05 ) ; the peak urinary flow rate after treatment in treatment group increased,PVR and WBC count in EPS decreased,(P ＜ 0.05 ).Conclusion The treatment group has most satisfactory improvements compared with the control group during the study.
Keywords：ProstatitisQianliejindanBenign prostatic hyperplasia
Publication Date：2012-01-01
Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)